Your search returned 25 results. Subscribe to this search

Not what you expected? Check for suggestions
|
1. 55O - Radiogenomic signatures of NSCLC brain metastases: A potential non-invasive imaging marker for ALK mutation.

by Wadhwa S | Krishna BG | Malhotra M | Prabhash K | Noronha V | Joshi A | Patil V | Mahajan A.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

2. 72PD MR Imaging Radiomics of NSCLC Brain Metastases: A Potential Targetable Imaging Biomarker for EGFR Status

by Mahajan A | Prabhash K | Ghaytidak A | Noronah V | Joshi A | Patil V.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

3. Authors’ reply to Batra et al., Chadha et al., and Deb et al

by Kapoor A | Noronha V | Chougule A [Corresponding Author ] | Patil VM | Menon N | Joshi A | Chandrani P | Kumar R | Talreja V | D'Souza H | Prabhash K.

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

4. Authors' reply to Dubey et al. and Bhattacharyya et al.

by Kapoor A | Noronha V | Shetty O | Chougule A | Chandrani P | Patil VM | Joshi A | Menon N | Kumar R | Gurav M | Kumar A | Prabhash K [Corresponding Author].

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

5. Coexistence of epidermal growth factor receptor mutation and anaplastic lymphoma kinase translocation in non-small cell lung cancer: Do we know the treatment sequence?

by Talreja VT | Noronha V [Corresponding Author] | Joshi A | Patil V | Mahajan A | Prabhash K.

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

6. A comparative pharmacokinetic study of 2 pemetrexed formulations in Indian adult chemonaive patients with adenocarcinoma stage III/IV non-small cell lung cancer.

by Kavathiya K | Gurjar M | Patil A | Naik M | Noronha V | Joshi A | Gota V | Prabhash K.

In Clinical Pharmacology in Drug Development
Material type: article Article; Format: print Publisher: Hoboken, NJ :, Wiley 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

7. The efficacy and safety of first‑line therapy for the epidermal growth factor receptor mutant non-small cell lung cancer in older versus younger patients: A pooled analysis of two randomized controlled trials

by Kapoor A | Noronha V | Patil VM | Joshi A | Menon N | Chougule A.

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

8. Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

by Joshi A | Noronha V | Patil VM | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K.

In Chemotherapy Research and Practice
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

9. Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management

by Rajendra A | Noronha V [Corresponding Author] | Joshi A | Patil VM | Menon N | Prabhash K.

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

10. An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome

by Talreja VT | Noronha V [Corresponding Author] | Joshi A | Patil V | Prabhash K.

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

11. The importance of brain metastasis in EGFR mutation positive NSCLC patients

by Noronha V | Prabhash K | Jambhekar N | Chougule A | Purandare N | Janu A | Patil V | Sharma V | Gokarn A | Joshi A.

In Chemotherapy Research and Practice
Material type: article Article; Format: print Publisher: 2015Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

12. LBA10 - A randomized investigator initiated phase III study comparing low dose gemcitabine to standard dose gemcitabine with platinum in advanced squamous non driver mutated non-small cell lung cancer

by Chandrashekharan A | Patil V | Noronha V | Joshi A | Choughle A | Punatar S | Mahajan A | Janu A | Purandare N | Goud S | More S | Das S | Agrawal A | Rajourohit A | Majumdar S | Khaddar S | Prabhash K.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

13. Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience.

by Talreja VT | Noronha V | Patil VM | Joshi A | Prabhash K [Corresponding Author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

14. Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis.

by Kate S | Chougule A | Joshi A | Noronha V | Patil V | Dusane R | Solanki L | Tiwrekar P | Trivedi V | Prabhash K [Corresponding author ].

In Lung Cancer
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

15. P1.01-44Outcome of Uncommon EGFR Mutation Positive NewlyDiagnosed Advanced NSCLC Patients: A Single-CentreRetrospective Analysis.

by Kate S | Choughule A | Joshi A | Noronha V | Patil V | Dusane R | Tiwrekar P | Solanki L | Trivedi V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

16. P3.02b-007 Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung

by Goel A | Joshi A | Patil V | Noronha V | Chougule A | Mahajan A | Janu A | Kaushal R | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Talreja V | Chanana R | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

17. P3.02b-058 Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial

by Ramaswamy A | Patil V | Joshi A | Noronha V | Choughule A | Mahajan A | Goud S | More S | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

18. P3.02b-090 Pemetrexed versus gefitinib in egfr mutation positive lung cancer: results of a phase 3 study from India

by Kumar Prabhash | Patil V | Joshi A | Noronha V | Chougule A | Mahajan A | Janu A | Goud S | More S | Kaushal R | Karpe A | Ramaswamy A | Pande N | Talreja V.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

19. Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

by Patil VM | Noronha V | Joshi A | Choughule AB | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In ESMO Open
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

20. Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer.

by Patil V | Joshi A | Noronha V | Kanan S | Agarwala V | Chougule A | Bhattacharjee A | Chandrasekharan A | Pande N | Simha V | Goud S | More S | Kumar R | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding Author].

In Oncotarget
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha